Marvin Hausman

Marvin Hausman

Patrimonio netto: 397 595 $ in data 30/09/2026

84 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Dr. Marvin S.
Hausman
, MD, is a Chairman & Chief Executive Officer at Total Nutraceutical Solutions, Inc., a President at Northwest Medical Research Partners, Inc., a Chief Scientific Officer at Ludwig Enterprises, Inc., a Chairman at SwabAi Diagnostics, Inc., a Chief Scientific Officer at Xycota Biosciences LLC and an Independent Director at NuGenerex Immuno-Oncology, Inc. He is on the Board of Directors at NuGenerex Immuno-Oncology, Inc. Dr. Hausman was previously employed as a Chief Scientific Officer by Lion Biotechnologies, Inc., a Chairman, Chief Science & Technology Officer by Entia Biosciences, Inc., a Chairman, President & Chief Executive Officer by OXIS International, Inc., a Chairman, President & Chief Executive Officer by Axonyx, Inc., a Member-Governors Board by New York University, a Member by American Association for the Advancement of Science, a Member by American Board of Urology, a Member by American College of Surgeons, a Member by American Federation for Medical Research, a Member by American Medical Association, a Member by American Urological Association Education & Research, Inc., a Member by Association for Academic Surgery, a Member by California Medical Association, a Co-Founder by King Pharmaceuticals Research & Development, Inc., a Research Associate by National Institutes of Health, a Member by New York Academy of Sciences, a Member by The American Association of Immunologists, a Member by The Royal Society of Medicine, and a Chairman & Chief Executive Officer by W World Corp.
He also served on the board at Arbios Technologies, Inc., OXIS International, Inc., Regent Assisted Living, Inc., TorreyPines Therapeutics, Inc. and Arbios Systems, Inc. He received his undergraduate degree from Brooklyn College and a doctorate degree from New York University School of Medicine.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
29/04/2026 37.758.000 ( 22,59% ) 377 580 $ 30/09/2026
16/06/2025 2.000.000 ( 28,57% ) 20 000 $ 30/09/2026
08/05/2017 14.625 ( -.--% ) 15 $ 30/09/2026

Posizioni attive di Marvin Hausman

SocietàPosizioneInizio
NUGENEREX IMMUNO-ONCOLOGY, INC. Direttore/Membro del Consiglio -
LUDWIG ENTERPRISES, INC. Fondatore 11/02/1988
Presidente -
Amministratore Delegato 01/10/2008
Northwest Medical Research Partners, Inc.
Fondatore 01/10/1995

Precedenti posizioni note di Marvin Hausman

SocietàPosizioneFine
IOVANCE BIOTHERAPEUTICS, INC. Direttore Tecnico/Scientifico/R&S 26/09/2013
GT BIOPHARMA, INC. Direttore Finanziario/CFO -
Direttore/Membro del Consiglio 23/05/2007
Amministratore Delegato 06/10/2006
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Marvin Hausman

Formazione di Marvin Hausman

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

84

Relazioni di 1° grado

30

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private30

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Government

Health Technology

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Northwest Medical Research Partners, Inc.

Commercial Services

Finance

Commercial Services

Association for Academic Surgery

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Marvin Hausman